Shanghai – September 25, 2026 -- Nutshell Therapeutics (Shanghai) Co., Ltd. has received FDA clearance of its Investigational New Drug (IND) application for NTS231, a covalent allosteric molecular glue degrader targeting NRF2, allowing the company to begin clinical development in the United States. NTS231 is the first NRF2 degrader originating from China and only the second such molecule worldwide to reach clinical-stage development.

Beijing – September 25, 2026 -- Yiren Digital Ltd. (NYSE: YRD) will release unaudited financial results for the second quarter ended June 30, 2026, before U.S. markets open on Wednesday, September 30, 2026.

Beijing – September 25, 2026 -- iQIYI unveiled a slate of more than 350 new titles for 2026-2027 at its iJOY Conference held September 23 in Shanghai, anchoring the launch around a new "All in AI" production and marketing strategy. The Chinese streaming platform also confirmed that its flagship Scream Night event will run December 5 at Galaxy Arena in Macao under a renewed three-year residency agreement covering 2026 to 2028.

Beijing -- Chinese President Xi Jinping announced on September 24, 2026 that China will invite 100,000 young Americans for exchange and study programs over the next five years, a pledge made during a White House welcome ceremony marking his state visit to the United States.

Boston and Shenzhen – September 24, 2026 -- XtalPi Holdings Limited (HKEX: 2228) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for KQTD-126, a potential first-in-class gut-restricted pan-tropomyosin receptor kinase (pan-TRK) inhibitor targeting chronic intestinal pain in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).

Quanzhou, China – September 24, 2026 -- INLIF LIMITED (Nasdaq: INLF) swung to a net income of $1.01 million in the first half of fiscal year 2026, reversing a $1.98 million net loss in the same period last year, an improvement of approximately $3.0 million.

Shanghai – September 24, 2026 -- Sanyou Biopharmaceuticals Co., Ltd. and NovoCodex Biopharmaceuticals Co., Ltd. have signed a strategic collaboration agreement to jointly develop next-generation antibody-drug conjugates (ADCs), combining Sanyou Bio's AI-driven antibody discovery platforms with NovoCodex's clinically validated site-specific conjugation technology.

Beijing – September 24, 2026 -- Honor's global smartphone shipments surpassed 71 million units in 2025, making it the fastest-growing leading smartphone vendor after the company's domestic market share had collapsed to just 3% following its November 2020 spinoff from Huawei.

Guangzhou – September 24, 2026 -- Pomdoctor Limited (NASDAQ: POM) outlined a differentiated "hardware plus AI plus payment" infrastructure model that it says sets the company apart from traditional internet healthcare platforms, which typically operate in silos around discrete services such as online consultations or pharmaceutical transactions.

Changzhou – September 24, 2026 -- Segway gathered more than 160 guests, including representatives from over 60 shared mobility operators, at its Changzhou facility this month to unveil new hardware and a fleet-economics framework aimed at shifting the shared micromobility industry from fleet-size growth toward profitability.